Inventor · disambiguated record
Michael A. Letavic
Also filed as: LETAVIC MICHAEL A · LETAVIC MICHAEL ANTHONY · LETAVIC Michael
65 granted patents·21 pending applications·575 citations·filing 1998–2024
99Inventor score
Files withJANSSEN PHARMACEUTICA NV44PFIZER17CARRUTHERS NICHOLAS I3Jansssen Pharmaceutica NV3LETAVIC MICHAEL A3
Top patents by PatentIndex Score
86 records- 0196US9464084B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Oct 11, 2016·16 cites·6 claims
- 0295US9066946B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jun 30, 2015·20 cites·32 claims
- 0395US6696464B2Triazolo-pyridines anti-inflammatory compoundsPFIZER·Filed 2002·Granted Feb 24, 2004·91 cites·53 claims
- 0494US11667644B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jun 6, 2023·2 cites·31 claims
- 0594US10150765B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Dec 11, 2018·11 cites·18 claims
- 0694US10071988B2Substituted 1,2,3-triazoles as NR2B-selective NMDA modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Sep 11, 2018·17 cites·22 claims
- 0794US9963447B2Substituted 4-azaindoles and their use as GluN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted May 8, 2018·17 cites·26 claims
- 0894US7030242B2Selective inhibition of aggrecanase in osteoarthritis treatmentPFIZER PROD INC·Filed 2005·Granted Apr 18, 2006·40 cites·3 claims
- 0993US10617676B2Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GluN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 14, 2020·12 cites·27 claims
- 1093US10233173B2Substituted 1,2,3-triazoles as NR2B-selective NMDA modulatorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Mar 19, 2019·13 cites·20 claims
- 1192US11820770B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Nov 21, 2023·1 cites·20 claims
- 1292US10377753B2Substituted 4-azaindoles and their use as GluN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Aug 13, 2019·13 cites·31 claims
- 1392US9079911B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jul 14, 2015·13 cites·17 claims
- 1492US8653263B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsCHAI WENYING·Filed 2010·Granted Feb 18, 2014·24 cites·30 claims
- 1591US10112937B2P2X7 modulators and methods of useJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Oct 30, 2018·11 cites·40 claims
- 1690US12247027B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2023·Granted Mar 11, 2025·0 cites·10 claims
- 1790US9586962B2Disubstituted octahydropyrrolo [3,4-C] pyrroles as orexin receptor modulatorsLETAVIC MICHAEL A·Filed 2012·Granted Mar 7, 2017·12 cites·14 claims
- 1890US9540388B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jan 10, 2017·5 cites·35 claims
- 1989US11530210B2Substituted heteroaromatic pyrazolo-pyridines and their use as GLUN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Dec 20, 2022·2 cites·129 claims
- 2089US11207298B2Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Dec 28, 2021·2 cites·32 claims
- 2189US11161846B2Substituted pyrazolo[4,3-b]pyridines and their use as GluN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Nov 2, 2021·2 cites·26 claims
- 2289US6777393B24″-substituted-9-deoxo-9a-aza-9a homoerythromycin a derivativePFIZER·Filed 2002·Granted Aug 17, 2004·28 cites·8 claims
- 2388US12378254B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2023·Granted Aug 5, 2025·0 cites·13 claims
- 2488US7005523B2Cycloalkyl-[4-(trifluorophenyl)-oxazol-5yl]-triazolo-pyridinesPFIZER·Filed 2003·Granted Feb 28, 2006·18 cites·8 claims
- 2587US11059828B2Disubstituted octahydropyrrolo[3,4-C]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jul 13, 2021·3 cites·21 claims
- 2686US11225478B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Jan 18, 2022·1 cites·46 claims
- 2785USRE48841EDisubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Dec 7, 2021·2 cites·37 claims
- 2885US10766880B2Substituted 1,2,3-triazoles as NR2B-selective NMDA modulatorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Sep 8, 2020·2 cites·27 claims
- 2984US10150766B2P2X7 modulatorsJansssen Pharmaceutica NV·Filed 2015·Granted Dec 11, 2018·7 cites·36 claims
- 3084US8680275B2Fused heterocyclic compounds as orexin receptor modulatorsBRANSTETTER BRYAN JAMES·Filed 2010·Granted Mar 25, 2014·9 cites·20 claims
- 3184US6599890B1Arylsulfonyl hydroxamic acid derivativesPFIZER·Filed 2000·Granted Jul 29, 2003·22 cites·8 claims
- 3283US10703749B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jul 7, 2020·1 cites·6 claims
- 3381US7687499B2Cyclopropyl amines as modulators of the histamine H3 receptorJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Mar 30, 2010·3 cites·10 claims
- 3481US2023338341A1SUBSTITUTED 1H-IMIDAZO[4,5-b]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORSJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 3579US6664395B2Benzotriazoles anti-inflammatory compoundsPFIZER·Filed 2002·Granted Dec 16, 2003·13 cites·50 claims
- 3678US8883776B2Cycloalkyloxy- and heterocycloalkyloxypyridine compounds as modulators of the histamine H3 receptorLETAVIC MICHAEL A·Filed 2008·Granted Nov 11, 2014·4 cites·16 claims
- 3778US8637520B2Substituted pyridyl amide compounds as modulators of the histamine H3 receptorKEITH JOHN M·Filed 2010·Granted Jan 28, 2014·4 cites·4 claims
- 3877US8940731B2Substituted pyridyl amide compounds as modulators of the histamine H3 receptorJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jan 27, 2015·2 cites·5 claims
- 3977US6407074B1C-4″-substituted macrolide derivativesPFIZER·Filed 1998·Granted Jun 18, 2002·43 cites·27 claims
- 4077US2025136598A1Substituted pyrazolo-pyridine amides and their use as glun2b receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 4176US7056918B2Benzimidazole anti-inflammatory compoundsPFIZER·Filed 2002·Granted Jun 6, 2006·10 cites·32 claims
- 4275US11759455B2Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Sep 19, 2023·0 cites·25 claims
- 4374US6576749B2C-4″-substituted macrolide derivativesPFIZER·Filed 2002·Granted Jun 10, 2003·5 cites·4 claims
- 4473US12172997B2Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Dec 24, 2024·0 cites·22 claims
- 4573US9096596B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 4, 2015·1 cites·22 claims
- 4672US9062044B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsBRANSTETTER BRYAN JAMES·Filed 2010·Granted Jun 23, 2015·2 cites·18 claims
- 4772US6936592B24″-substituted-9-deoxo-9a-aza-9a-homoerythromycin A derivativesPFIZER·Filed 2004·Granted Aug 30, 2005·3 cites·1 claims
- 4868US7259171B2Di and trifluoro-triazolo-pyridines anti-inflammatory compoundsPFIZER·Filed 2003·Granted Aug 21, 2007·3 cites·29 claims
- 4967US12338243B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Jun 24, 2025·0 cites·23 claims
- 5067US9102686B25,6,7,8,9,10-hexahydro-6,10-epimino[1,2,4]triazolo[4,3-a]azocines as P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 11, 2015·0 cites·30 claims
Showing the top 50 of 86 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael A. Letavic files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →